pubmed-article:10559581 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C0033860 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C0439662 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:10559581 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:10559581 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:10559581 | pubmed:dateCreated | 2000-1-11 | lld:pubmed |
pubmed-article:10559581 | pubmed:abstractText | Psoriasis is a T-cell mediated autoimmune disease. The objective of this work was to investigate the presence of cellular and soluble activation molecules in the blood of patients with psoriasis, not responding to local treatment and to study the effect of cyclosporin A (CsA) on these markers. | lld:pubmed |
pubmed-article:10559581 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:language | eng | lld:pubmed |
pubmed-article:10559581 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10559581 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10559581 | pubmed:issn | 1018-8665 | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:EconomidouJJ | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:KatsambasAA | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:DegiannisDD | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:VareltzidisAA | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:AvgerinouGG | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:PsarraKK | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:BarkisJJ | lld:pubmed |
pubmed-article:10559581 | pubmed:author | pubmed-author:DemetriouZZ | lld:pubmed |
pubmed-article:10559581 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10559581 | pubmed:volume | 199 | lld:pubmed |
pubmed-article:10559581 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10559581 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10559581 | pubmed:pagination | 144-8 | lld:pubmed |
pubmed-article:10559581 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:meshHeading | pubmed-meshheading:10559581... | lld:pubmed |
pubmed-article:10559581 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10559581 | pubmed:articleTitle | Effects of cyclosporin A on immune activation markers in patients with active psoriasis. | lld:pubmed |
pubmed-article:10559581 | pubmed:affiliation | Department of Dermatology-Venereology University of Athens, Athens, Greece. | lld:pubmed |
pubmed-article:10559581 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10559581 | lld:pubmed |